Nephrogenic fibrosing dermopathy

American Journal of Dermatopathology

Volumn 23, Issue 5, 2001, Pages 383-393

  Cowper, Shawn E ^a,f   Su, Lyndon D ^b   Bhawan, Jag ^c   Robin, Howard S ^d   LeBoit, Philip E ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SHARP HEALTHCARE   (United States)

^e Dermatopathology Section   (United States)

^f YALE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD 34; Dendritic cells; Dendrocytes; Dermis; Dialysis; Elastin; Factor XIIIa; Fibrosis; Kidney; Mucin; Renal; Scleroderma; Scleromyxedema; Scleromyxoedema; Skin; Ultrastructure

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD34 ANTIGEN; CD68 ANTIGEN; COLLAGEN; ELASTIN; MUCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DENDRITIC CELL; DERMIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROBLAST; FIBROSIS; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIMB; MALE; MYXEDEMA; NEPHROGENIC FIBROSING DERMOPATHY; PAPULE; PRIORITY JOURNAL; SARCOMA; SCLEROMYXEDEMA; SKIN MANIFESTATION; SPINDLE CELL; TRUNK;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; SKIN; SKIN DISEASES;

EID: 0034790497     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200110000-00001     Document Type: Article

References (30)

1. Scleromyxoedemalike cutaneous diseases in renal-dialysis patients
2. Modified russel-movat pentachrome method
3. Scleromyxedema
4. Scleromyxedema: A scleroderma-like disorder with systemic manifestations
5. Fatal scleromyxedema: Report of a case and review of the literature
6. The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis)
7. Rapidly progressive and fatal scleromyxedema in an adolescent with Crohn's disease
8. Scleromyxedema
9. Scleromyxedema: A variant of lichen myxedematosus
10. CD-34+ spindle-shaped cells selectively disappear from the skin lesions of scleroderma
11. Classification of morphea (localized scleroderma)
12. Morphea profunda: A new concept and a histopathologic study of 23 cases
13. Scleroderma
14. Histopathologic differentiation between localized and systemic scleroderma
15. Systemic scleroderma: Clinical and physiological aspects
16. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: A new syndrome?
17. Eosinophilic Fasciitis
18. A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome
19. Centers for Disease Control: Eosinophilia-myalgia syndrome - New Mexico
20. Unraveling the eosinophilia-myalgia syndrome
21. Eosinophilia-myalgia syndrome
22. Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
23. Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders
24. Cutaneous manifestations of the L-tryptophan-associated eosinophiliamyalgia syndrome: A spectrum of sclerodermatous skin disease
25. Tryptophan-Associated Eosinophilic Connective-Tissue Disease-A new clinical entity?
26. Histopathologic features of the L-tryptophan-related eosinophilia-myalgia (fasciitis) syndrome
27. Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain
28. T cells ignore aniline, a prohapten, but respond to its reactive metabolites generated by phagocytes: Possible implications for the pathogenesis of toxic oil syndrome
29. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the spanish toxic oil syndrome
30. Atypical β-2 microglobulin amyloidosis following short-term hemodialysis